vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and Silvercrest Asset Management Group Inc. (SAMG). Click either name above to swap in a different company.
Silvercrest Asset Management Group Inc. is the larger business by last-quarter revenue ($32.0M vs $20.0M, roughly 1.6× AGIOS PHARMACEUTICALS, INC.). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -541.1%, a 540.7% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs -0.0%). Silvercrest Asset Management Group Inc. produced more free cash flow last quarter ($15.0M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs 2.7%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
AGIO vs SAMG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $32.0M |
| Net Profit | $-108.0M | $-120.0K |
| Gross Margin | 90.6% | — |
| Operating Margin | -608.9% | -2.8% |
| Net Margin | -541.1% | -0.4% |
| Revenue YoY | 86.1% | -0.0% |
| Net Profit YoY | -11.9% | -107.4% |
| EPS (diluted) | $-1.86 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $32.0M | ||
| Q3 25 | $12.9M | $31.3M | ||
| Q2 25 | $12.5M | $30.7M | ||
| Q1 25 | $8.7M | $31.4M | ||
| Q4 24 | $10.7M | $32.0M | ||
| Q3 24 | $9.0M | $30.4M | ||
| Q2 24 | $8.6M | $31.0M | ||
| Q1 24 | $8.2M | $30.3M |
| Q4 25 | $-108.0M | $-120.0K | ||
| Q3 25 | $-103.4M | $618.0K | ||
| Q2 25 | $-112.0M | $1.9M | ||
| Q1 25 | $-89.3M | $2.5M | ||
| Q4 24 | $-96.5M | $1.6M | ||
| Q3 24 | $947.9M | $2.3M | ||
| Q2 24 | $-96.1M | $2.7M | ||
| Q1 24 | $-81.5M | $3.0M |
| Q4 25 | 90.6% | — | ||
| Q3 25 | 87.0% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 87.6% | — | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 92.3% | — |
| Q4 25 | -608.9% | -2.8% | ||
| Q3 25 | -907.4% | 4.3% | ||
| Q2 25 | -1020.1% | 13.2% | ||
| Q1 25 | -1222.0% | 15.4% | ||
| Q4 24 | -1165.3% | 6.1% | ||
| Q3 24 | -1146.9% | 14.6% | ||
| Q2 24 | -1228.3% | 17.1% | ||
| Q1 24 | -1124.3% | 19.5% |
| Q4 25 | -541.1% | -0.4% | ||
| Q3 25 | -803.1% | 2.0% | ||
| Q2 25 | -899.4% | 6.3% | ||
| Q1 25 | -1023.3% | 7.9% | ||
| Q4 24 | -899.6% | 5.1% | ||
| Q3 24 | 10574.7% | 7.4% | ||
| Q2 24 | -1115.7% | 8.6% | ||
| Q1 24 | -995.8% | 9.9% |
| Q4 25 | $-1.86 | $0.02 | ||
| Q3 25 | $-1.78 | $0.07 | ||
| Q2 25 | $-1.93 | $0.21 | ||
| Q1 25 | $-1.55 | $0.26 | ||
| Q4 24 | $-1.44 | $0.16 | ||
| Q3 24 | $16.22 | $0.24 | ||
| Q2 24 | $-1.69 | $0.28 | ||
| Q1 24 | $-1.45 | $0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $44.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $50.3M |
| Total Assets | $1.3B | $166.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | $44.1M | ||
| Q3 25 | $92.7M | $36.1M | ||
| Q2 25 | $80.9M | $30.0M | ||
| Q1 25 | $79.0M | $36.3M | ||
| Q4 24 | $76.2M | $68.6M | ||
| Q3 24 | $253.7M | $58.1M | ||
| Q2 24 | $84.5M | $49.9M | ||
| Q1 24 | $118.8M | $39.7M |
| Q4 25 | $1.2B | $50.3M | ||
| Q3 25 | $1.3B | $58.9M | ||
| Q2 25 | $1.4B | $64.6M | ||
| Q1 25 | $1.5B | $80.0M | ||
| Q4 24 | $1.5B | $80.7M | ||
| Q3 24 | $1.6B | $84.6M | ||
| Q2 24 | $660.5M | $85.3M | ||
| Q1 24 | $743.9M | $83.9M |
| Q4 25 | $1.3B | $166.6M | ||
| Q3 25 | $1.4B | $157.6M | ||
| Q2 25 | $1.5B | $152.7M | ||
| Q1 25 | $1.6B | $159.9M | ||
| Q4 24 | $1.7B | $194.4M | ||
| Q3 24 | $1.8B | $184.2M | ||
| Q2 24 | $773.1M | $177.6M | ||
| Q1 24 | $849.7M | $170.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $18.6M |
| Free Cash FlowOCF − Capex | $-97.3M | $15.0M |
| FCF MarginFCF / Revenue | -487.5% | 46.9% |
| Capex IntensityCapex / Revenue | 5.6% | 11.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $17.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $18.6M | ||
| Q3 25 | $-88.2M | $14.6M | ||
| Q2 25 | $-77.1M | $13.8M | ||
| Q1 25 | $-111.5M | $-24.7M | ||
| Q4 24 | $-133.2M | $21.6M | ||
| Q3 24 | $-84.2M | $13.3M | ||
| Q2 24 | $-72.6M | $16.0M | ||
| Q1 24 | $-99.9M | $-24.1M |
| Q4 25 | $-97.3M | $15.0M | ||
| Q3 25 | $-89.7M | $13.8M | ||
| Q2 25 | $-78.0M | $13.4M | ||
| Q1 25 | $-112.3M | $-25.1M | ||
| Q4 24 | $-134.1M | $19.9M | ||
| Q3 24 | $-84.6M | $12.9M | ||
| Q2 24 | $-72.7M | $15.6M | ||
| Q1 24 | $-100.0M | $-24.7M |
| Q4 25 | -487.5% | 46.9% | ||
| Q3 25 | -696.5% | 44.1% | ||
| Q2 25 | -626.2% | 43.6% | ||
| Q1 25 | -1286.4% | -80.0% | ||
| Q4 24 | -1250.1% | 62.2% | ||
| Q3 24 | -944.2% | 42.4% | ||
| Q2 24 | -844.4% | 50.4% | ||
| Q1 24 | -1221.2% | -81.6% |
| Q4 25 | 5.6% | 11.4% | ||
| Q3 25 | 12.1% | 2.6% | ||
| Q2 25 | 7.0% | 1.5% | ||
| Q1 25 | 8.8% | 1.3% | ||
| Q4 24 | 9.0% | 5.3% | ||
| Q3 24 | 4.7% | 1.2% | ||
| Q2 24 | 1.8% | 1.1% | ||
| Q1 24 | 1.7% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 23.62× | ||
| Q2 25 | — | 7.22× | ||
| Q1 25 | — | -10.01× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | -0.09× | 5.90× | ||
| Q2 24 | — | 6.00× | ||
| Q1 24 | — | -8.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGIO
Segment breakdown not available.
SAMG
| Investment Advisory Management And Administrative Service | $30.7M | 96% |
| Tax And Family Office Services | $1.2M | 4% |
